Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

R&D Systems | Catalog # MAB10348

Recombinant Monoclonal Antibody For Research Use Only
R&D Systems

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Blockade of Receptor-ligand Interaction, Flow Cytometry, CyTOF-ready

Cited:

Neutralization

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Human IgG1 Clone # Hu124
Loading...

Product Specifications

Immunogen

Human PD-L1/B7-H1

Specificity

Detects Human PD-L1/B7-H1 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Atezolizumab. This product is for research use only.

Clonality

Monoclonal

Host

Human

Isotype

IgG1

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

Detection of PD-L1/B7-H1 antibody in MDA-MB-231 human breast adenocarcinoma cell line antibody by Flow Cytometry.

Detection of PD-L1/B7-H1 in MDA-MB-231 human breast adenocarcinoma cell line by Flow Cytometry.

MDA-MB-231 human breast adenocarcinoma cell line was stained with Human Anti-Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Monoclonal Antibody (Catalog # MAB10348, filled histogram) or irrelevant antibody (open histogram) followed by APC-conjugated Anti-Human IgG Secondary Antibody (F0135). View our protocol for Staining Membrane-associated Proteins.

PD-1 binding to Human PD-L1/B7-H1-transfected HEK293 Human Cell Line is Blocked by Human PD-L1/B7-H1 Antibody.

In a functional flow cytometry test, Recombinant Human PD-1 His-tagged protein (8986-PD, 500 ng/mL) binds to HEK293 human embryonic kidney cell line transfected with recombinant human PD-L1/B7-H1. (A) Binding is completely blocked by 2.5 µg/mL of Human Anti-Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Monoclonal Antibody (Catalog # MAB10348) but not by (B) Human IgG Isotype Control (1-001-A). Ligand binding was detected by staining cells with Anti-His tag APC-conjugated Monoclonal Antibody (IC050A).

Applications for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

Application
Recommended Usage

Blockade of Receptor-ligand Interaction

In a functional flow cytometry test, 2.5 μg/mL of Human anti-human PD-L1/B7-H1 (Atezoliumab Biosimilar) Antibody(Catalog # MAB10348) will block the binding of Recombinant Human PD-1 His-tagged protein (Catalog # 8986-PD) to HEK293 human embryonic kidney cell line transfected with recombinant human PD-L1/B7-H1.

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Flow Cytometry

0.25 µg/106 cells
Sample: MDA-MB-231 human breast adenocarcinoma cell line

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Protein A or G purified from cell culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: PD-L1/B7-H1

Atezolizumab is a biosimilar directed against human PD-L1.

Long Name

Programmed Death Ligand 1

Alternate Names

B7-H1, B7H1, CD274, PDCD1L1, PDCD1LG1, PDL1

Entrez Gene IDs

29126 (Human); 60533 (Mouse); 499342 (Rat); 574058 (Porcine); 484186 (Canine); 102145573 (Cynomolgus Monkey)

Gene Symbol

CD274

Additional PD-L1/B7-H1 Products

Product Documents for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

For research use only

Citations for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

Customer Reviews for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

There are currently no reviews for this product. Be the first to review Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody and earn rewards!

Have you used Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

FAQs for Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody

Showing  1 - 2 of 2 FAQs Showing All
  • Q: Does this Biosimilar antibody have the same sequence as the therapeutic antibody?

    A: The Biosimilar antibody has the same variable region and constant region sequence as the therapeutic antibody, except for Catalog numbers MAB9677, MAB9575, MAB9577, MAB9589, and their conjugates. These four antibodies have the same variable region as the Biosimilar, but not the same constant region.

  • Q: Is the Fc portion of Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody, Catalog # MAB10348, inert, similar to what has been reported with the therapeutic Atezolizumab?

    A: We have not performed any testing in house to confirm that the Fc portion is inert, but the sequence of MAB10348 is the same as the therapeutic Atezolizumab. 

  • Q: Does this Biosimilar antibody have the same sequence as the therapeutic antibody?

    A: The Biosimilar antibody has the same variable region and constant region sequence as the therapeutic antibody, except for Catalog numbers MAB9677, MAB9575, MAB9577, MAB9589, and their conjugates. These four antibodies have the same variable region as the Biosimilar, but not the same constant region.

  • Q: Is the Fc portion of Human PD-L1/B7-H1 (Research Grade Atezolizumab Biosimilar) Antibody, Catalog # MAB10348, inert, similar to what has been reported with the therapeutic Atezolizumab?

    A: We have not performed any testing in house to confirm that the Fc portion is inert, but the sequence of MAB10348 is the same as the therapeutic Atezolizumab. 

Showing  1 - 2 of 2 FAQs Showing All
View all FAQs for Antibodies
Loading...